Key facts
- Clarium’s last known valuation is $140.0M (May 2025).
- It has raised $42.5M; the latest was Later Stage VC ($27.0M) in May 2025.
- Notable investors include Alumni Ventures, General Catalyst, Texas Medical Center, AlleyCorp, Northzone Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Clarium
- ·The full record, as it builds
Funding rounds
No funding rounds for Clarium are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Clarium
Developer of an artificial intelligence-based platform designed to automate healthcare business operations. The company's platform collects data from the existing systems and filters for noise, error, and outliners to predict demand and automate staffing and supplies, enabling hospitals and healthcare centers to avoid shortages and stockouts, reduce supplier lead times, and identify alternative products.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 37
- Website
- clariumhealth.com/
- Ownership
- Privately Held (backing)
Clarium doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clarium shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clarium in its N-PORT filings yet. We sweep new filings monthly.